1. Home
  2. TMDX vs PSEC Comparison

TMDX vs PSEC Comparison

Compare TMDX & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • PSEC
  • Stock Information
  • Founded
  • TMDX 1998
  • PSEC 2004
  • Country
  • TMDX United States
  • PSEC United States
  • Employees
  • TMDX N/A
  • PSEC N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PSEC Finance/Investors Services
  • Sector
  • TMDX Health Care
  • PSEC Finance
  • Exchange
  • TMDX Nasdaq
  • PSEC Nasdaq
  • Market Cap
  • TMDX 2.3B
  • PSEC 1.9B
  • IPO Year
  • TMDX 2019
  • PSEC 2004
  • Fundamental
  • Price
  • TMDX $68.58
  • PSEC $4.12
  • Analyst Decision
  • TMDX Buy
  • PSEC Sell
  • Analyst Count
  • TMDX 10
  • PSEC 1
  • Target Price
  • TMDX $118.44
  • PSEC $4.50
  • AVG Volume (30 Days)
  • TMDX 929.2K
  • PSEC 2.6M
  • Earning Date
  • TMDX 04-29-2025
  • PSEC 05-07-2025
  • Dividend Yield
  • TMDX N/A
  • PSEC 15.31%
  • EPS Growth
  • TMDX N/A
  • PSEC N/A
  • EPS
  • TMDX 1.01
  • PSEC N/A
  • Revenue
  • TMDX $441,540,000.00
  • PSEC $796,249,000.00
  • Revenue This Year
  • TMDX $25.24
  • PSEC N/A
  • Revenue Next Year
  • TMDX $19.89
  • PSEC N/A
  • P/E Ratio
  • TMDX $67.90
  • PSEC N/A
  • Revenue Growth
  • TMDX 82.74
  • PSEC N/A
  • 52 Week Low
  • TMDX $55.00
  • PSEC $4.09
  • 52 Week High
  • TMDX $177.37
  • PSEC $5.72
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 47.95
  • PSEC 33.02
  • Support Level
  • TMDX $66.69
  • PSEC $4.21
  • Resistance Level
  • TMDX $73.68
  • PSEC $4.28
  • Average True Range (ATR)
  • TMDX 3.42
  • PSEC 0.07
  • MACD
  • TMDX 0.17
  • PSEC -0.01
  • Stochastic Oscillator
  • TMDX 53.89
  • PSEC 5.77

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About PSEC Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

Share on Social Networks: